Deep dermatophytosis during topical tacrolimus therapy for psoriasis [2]

Acta Dermato-Venereologica

Volumn 83, Issue 4, 2003, Pages 291-292

  Yamamoto, Toshiyuki ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETINATE; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS;

ADULT; ALOPECIA AREATA; ATOPIC DERMATITIS; BURN; CASE REPORT; DERMATOMYCOSIS; DRUG ACTIVITY; DRUG EFFICACY; ERYTHEMA; FLU LIKE SYNDROME; HEADACHE; HERPES SIMPLEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LICHEN PLANUS; MALE; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PYODERMA GANGRENOSUM; STREPTOMYCES TSUKUBAENSIS;

ADMINISTRATION, CUTANEOUS; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; FACIAL DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PSORIASIS; TACROLIMUS;

EID: 0042170080     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550310016571     Document Type: Letter

References (6)

1. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, et al. FK-506, a novel immunosuppressant isolated from streptomyces. II: Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987; 40: 1256-1265.
2. Ruzicka T, Assmann T, Homey B. Tacrolimus. The drug for the turn of the millennium? Arch Dermatol 1999; 135: 574-580.
3. Skaehill PA. Tacrolimus in dermatologic disorders. Ann Pharmacother 2001; 35: 582-588.
4. Yamamoto T, Nishioka K. Topical tacrolimus is effective for facial psoriasis. Acta Derm Venereol 2000; 80: 451.
5. Soter NA, Fleischer Jr AB, Webster GF, Monroe EM, Lawrence I, and the tacrolimus ointment study group. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol 2001; 44: S39-S46.
6. Reitamo S, Wollenberg A, Schöpf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000; 136: 999-1006.